ADORA2A and Parkinson disease: In Parkinson’s disease, dopamine signaling to both the direct and indirect pathway is reduced, causing slow and dysregulated movements Furthermore, abnormal activation of the indirect pathway can be enhanced via adenosine A2A receptors overexpressed in progression of the disease, causing further dysfunction of movement.